Connect with us

Technology

ConcertAI’s TeraRecon Launches Three New Care Suites, Life Sciences Platform, and Strategic Partnerships at #ECR24

Published

on

New Clinical AI care suites for Cardiology, Pulmonology, and Neurology; First-in-Class multi-modal predictive and Gen AI platform for research and clinical model development.

CAMBRIDGE, Mass., Feb. 26, 2024 /PRNewswire/ — ConcertAI‘s TeraRecon, the #1 KLAS-ranked advanced visualization and AI Clinical SaaS solution, has announced that European healthcare providers now have access to its cardiology, pulmonology, and neurology suites. In addition, the company initiated new partnerships with several leading CE-marked AI software developers, including Gleamer, Lucida Medical, and Perspectum. TeraRecon now provides a leading unified solution for clinical AI algorithms in Europe across radiology, neurology, oncology, pulmonology, and cardiology.

TeraRecon’s AI Partnerships for the EU market now include:

GLEAMER brings their groundbreaking BoneView solution, CE marked and FDA-cleared, utilizes AI for bone fracture identification. Meanwhile, ChestView (CE) aids in the detection of pulmonary nodules.Lucida Medical AI-machine learning software, Pi™, is designed to help radiologists identify prostate cancer lesions from MRI.Perspectum’s LiverMultiscan and MRCP+ provide clinicians with quantitative metrics to assess liver tissue characteristics to aid in the detection of chronic live disease and helps facilitate visualization and quantitative assessment of the biliary tree and pancreatic duct.

Schedule a demo at ECR 2024 to see both TeraRecon and partner solutions live. You can also reserve time to see the new features of our flagship Intuition product, including clinical and interventional preoperative cardiovascular planning workflows, cardiac CT and MR workflows, and many more enhancements that integrate seamlessly within the clinicians’ workflow to enhance diagnostics, care delivery and tracking over time.

Please join us and Cercare Medical for a joint networking event in Expo Hall X1, at booths AI05 & AI06 on Friday, March 1st from 3:30 – 5:00 PM. You’ll be able to meet fellow radiologists, developers, subject matter experts, and representatives that can answer all your questions around Clinical Imaging AI in general across radiology, neurology, cardiology, vascular surgery, and oncology.

Outside the show floor, TeraRecon and Perspectum will present an AI Lightning Talk, titled Integrating AI in Clinical Care on Friday March 1st @ 12:50PM.

Another exciting launch at ECR is an integrated multi-modal data AI Software-as-a-Service platform designed for oncology biomedical translational and clinical research, AI model development, multi-modal data management. This first-in-class platform seamlessly integrates Intuition advanced visualization, TeraRecon clinical AI imaging solutions, digital pathology, genomics, and electronic medical record derived clinical data.

“Over the past two years, we have focused on the importance of multi-modal data AI model development, validation, stability monitoring, and deployment for insights, as part of clinical trials, and ultimately, clinical care,” said Jeff Elton, PhD CEO of ConcertAI. “Multi-modal data enable causal inferences and elimination of confounders for interpretations and predictions. Enabling this required rethinking the tools available to biomedical researchers, while leveraging the power of Generative AI. As a ground-up new approach that allows multi-modal data management, AI model development validation, model management, and model release we can bring the power of deep and wide data at scale, our large research network, and latest predictive AI and Gen AI together for the broadest research community use.”

About ConcertAI: ConcertAI is the leader in Predictive and Generative AI SaaS and Real-world Data research solutions and healthcare and life sciences. Our mission is to accelerate insights and outcomes for patients through research-ready data, CARA™ AI technologies, and scientific expertise in partnership with the leading biomedical innovators, health care providers, and medical societies.  Serving over 1,900 clinical sites and 45 biomedical innovators ConcertAI companies and solutions are “Best in KLAS” and awarded the 2020, 2021, and 2022 KLAS recognition. CancerLinQ® is an Initiative of ConcertAI, providing oncology providers ASCO aligned automated QOPI quality solutions and SmartLinQ analytic services. Headquartered in Cambridge, MA, ConcertAI has offices in Philadelphia, Frankfurt, Raleigh-Durham, and Tokyo. For more information, visit us at www.concertai.com.

About TeraRecon: Serving ~1,900 clinical sites globally, TeraRecon, a ConcertAI company, is a Best in KLAS solution provider for AI-empowered radiology, oncology, cardiology, neurology, and vascular surgery. Awarded the KLAS Category Leader for Advanced Visualization, TeraRecon solutions are independent of any one manufacturer’s imaging equipment or PACS system, allowing a single, unified, and simplified clinical workflow that can improve efficiencies and deliver actionable physician-guided insights. For more information, visit us at www.terarecon.com.

Media Contact: Megan Duero, megan@galestrategies.com

View original content:https://www.prnewswire.com/news-releases/concertais-terarecon-launches-three-new-care-suites-life-sciences-platform-and-strategic-partnerships-at-ecr24-302071222.html

SOURCE ConcertAI

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

AMTD’s TGE Reports Full Year Results with 27.7% Increase in Revenue, with 25.5% Increase in Total Assets and 9.1% Increase in Net Assets

Published

on

By

PARIS and LONDON and NEW YORK, April 29, 2026 /PRNewswire/ — The Generation Essentials Group (“TGE” or the “Company”) (NYSE: TGE, LSE; TGE), a NYSE and LSE dual-listed company and a subsidiary of AMTD Group Inc., today announced the filing of its annual report on Form 20-F for the fiscal year ended December 31, 2025 with the Securities and Exchange Commission, with summary highlights below:

Total Revenue increased by 27.7% from US$77.0 million to US$98.3 millionTotal non-GAAP Net Income increased by 3.2% from US$44.7 million to US$46.2 million Total Assets amounted to US$1,464.1 million (US$30.2/share)Net asset value amounted to US$839.1 million (US$17.3/share)

The annual report is available on the Company’s investor relations website at  http://thegenerationalessentials.com. The Company will provide a hard copy of its annual report containing the audited consolidated financial statements, free of charge, to its shareholders upon request. Requests should be directed to Investor Relations Office at ir@tge.media.

About The Generation Essentials Group

The Generation Essentials Group (NYSE: TGE; LSE: TGE), jointly established by AMTD Group, AMTD IDEA Group (NYSE: AMTD; SGX: HKB) and AMTD Digital Inc. (NYSE: HKD), is headquartered in France and focuses on global strategies and developments in multi-media, entertainment, and cultural affairs worldwide as well as hospitality and VIP services. TGE comprises L’Officiel, The Art Newspaper, movie and entertainment projects. Collectively, TGE is a diversified portfolio of media and entertainment businesses, and a global portfolio of premium properties. Also, TGE is a special purpose acquisition company (SPAC) sponsor manager, with its first SPAC successfully raised and priced on December 18, 2025.

For The Generation Essentials Group:
IR Office
The Generation Essentials Group
EMAIL: ir@tge.media

View original content:https://www.prnewswire.com/news-releases/amtds-tge-reports-full-year-results-with-27-7-increase-in-revenue-with-25-5-increase-in-total-assets-and-9-1-increase-in-net-assets-302757926.html

SOURCE The Generation Essentials Group

Continue Reading

Technology

Potatoes USA Awarded Patent for AI-Driven Social Media Monitoring and Responding

Published

on

By

DENVER, April 29, 2026 /PRNewswire/ — Potatoes USA, the national promotion board for U.S. potato growers and importers, has been awarded a patent (US 12,591,622 B2) for a method for monitoring and responding to social media content.

The innovative technology automates social media management, featuring AI-driven monitoring, content identification, and natural language response generation on a knowledge basis. The system may include a human-in-the-loop interface that allows for the review, editing, and approval of generated content prior to publication.

Potatoes USA uses the technology to monitor for misinformation about potato nutrition so they can respond with the correct information, educating consumers on the nutritional benefits of potatoes. Additionally, the organization uses the technology to participate in positive conversations about potatoes, joining in the vast amount of potato love on social media.

“For any company or brand trying to share information and raise awareness, it’s vital to be part of relevant conversations happening on social media. This technology allows us to participate in and, more importantly, help shape those conversations,” said Blair Richardson, CEO of Potatoes USA. “A huge number of people talk about potatoes on social media every day. The vast majority of what we see is very positive, but we also find negative and incorrect posts and comments about potatoes. Even though it’s a smaller percentage of what’s being said, it’s a key piece of our communications strategy to correct the misinformation that’s out there, debunk longstanding myths about potatoes, and educate the public on the true nutritional benefits of potatoes.”

The patented technology allows Potatoes USA to establish itself as a go-to resource on social media for potato nutrition facts, recipe inspiration, and general potato love.

About Potatoes USA
As representatives of U.S. potato growers and importers, Potatoes USA’s mission is to strengthen the demand for potatoes through marketing and research. By launching impactful marketing campaigns; coordinating regional, national, and international market and production research; and establishing new trade markets, Potatoes USA promotes the benefits of potatoes to audiences across the globe, including consumers, foodservice operators, retailers, and health professionals. For more information on America’s Favorite Vegetable, please visit PotatoGoodness.com and PotatoesUSA.com.

Media Contact
Erin Bracken
media@hillenby.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/potatoes-usa-awarded-patent-for-ai-driven-social-media-monitoring-and-responding-302757930.html

SOURCE Potatoes USA

Continue Reading

Technology

TERAGO to Hold Investor Conference Call to Discuss First Quarter 2026 Financial Results

Published

on

By

TORONTO, April 29, 2026 /CNW/ – TERAGO Inc. (“TERAGO” or the “Company”) (TSX: TGO) www.terago.ca, Canada’s 91% mmWave spectrum holder and a leading provider of Managed Fixed Wireless Internet, 5G Private Wireless Networks and SD-WAN secure solutions today announced that it will be hosting a conference call on Wednesday, May 13, 2026, at 10:00 a.m. ET to discuss its financial results for the first quarter of 2026. The complete financial results are expected to be released after market close on Tuesday, May 12, 2026.

The Company’s results along with a presentation in connection with the conference call will be made available on the Company’s website at https://terago.ca/company/investor-relations/.

To access the conference call, please dial 888-506-0062 or 973-528-0011 and use conference ID 135943 if applicable. Please call the conference telephone number 15 minutes prior to the start time so that you are in the queue for an operator to assist in registering and patching you through.

A replay of the conference call will be available through Wednesday, May 27, 2026 and can be accessed by dialing 877-481-4010 or 919-882-2331 and using passcode 53968.

About TERAGO
TERAGO provides managed network and security services to businesses across Canada ensuring highly secure, reliable and redundant connectivity including private 5G wireless networks, fixed wireless access, fiber and cable wireline network connectivity. As Canada’s biggest mmWave spectrum holders, the Company possesses exclusive spectrum licenses in the 24 GHz and 38 GHz spectrum bands, which it utilizes to provide secure, dedicated SLA guaranteed enterprise grade performance that is technology diverse from buried cables ensuring high availability connectivity services. TERAGO serves Canadian and Global businesses operating in major markets across Canada, including Toronto, Montreal, Calgary, Edmonton, Vancouver, Ottawa and Winnipeg, and has been providing wireless services since 1999. For more information about TERAGO and its suite of wireless internet and SDWAN solutions, please visit www.terago.ca.

SOURCE TeraGo Inc.

Continue Reading

Trending